Investor RelationsCOVID-19
  1. Home
  2. News & Stories
  3. Co-existing Coronary Artery Disease in a Patient with Hypertrophic Cardiomyopathy Detected by 82Rb PET/CT Myocardial Perfusion Study

Co-existing Coronary Artery Disease in a Patient with Hypertrophic Cardiomyopathy Detected by 82Rb PET/CT Myocardial Perfusion Study

By Parthiban Arumugam, MD, Data courtesy of Manchester Royal Infirmary, Manchester, England|2018-04-14
Clinical case study on co-existing coronary artery disease in a patient with hypertrophic cardiomyopathy detected by 82Rb PET/CT myocardial perfusion study.

A 58-year-old man with a history of hypertrophic cardiomyopathy (HCM) presented with tightness in the chest and occasional chest pain. The patient had previously been treated with alcohol septal ablation for a left ventricular outflow tract (LVOT) obstruction secondary to HCM. The patient also had several risk factors for coronary artery disease including high BMI (36), hypertension, and diabetes. In view of the clinical possibility of coronary artery disease coexisting with hypertrophic cardiomyopathy, the patient was referred to a stress-rest 82Rb PET/CT myocardial perfusion (MPI) study.

Download the full clinical case here.

The outcomes by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.